Exai Bio Expands RNA-based Breast Cancer Liquid Biopsy Platform through Collaboration
Exai Bio is collaborating with Quantum Leap Healthcare Collaborative to broaden the use of its novel, RNA-based liquid biopsy platform.
Category: Breast
Breast
Latest
Breast
Latest
RNA-Based Liquid Biopsy Platform Detects Early-Stage Breast Cancer
Researchers released data demonstrating that an RNA-based liquid biopsy platform accurately detected breast cancer at the earliest stages.
Breast
Latest
Cancer Diagnoses Continue to Lag During Pandemic
More than two years after the COVID-19 pandemic began, cancer diagnoses continue to lag behind pre-pandemic levels.
ASCO Clinical Practice Guideline Adds BCI to Guide Extended Endocrine Therapy Decisions
The ASCO has expanded the utility of BCI in its guideline: “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.”
Read More
DCIS Test Identifies Patients in Need of Intensified Therapy
This study validated the clinical utility of a DCIS test to predict recurrence risk and radiation therapy benefit in certain patients
Read More
Scientists Identify Cancer Biomarkers in Breast Milk
Proteins could one day allow breast cancer screenings to be done via blood test thanks to new biomarkers identified in breast milk.
Read More
Liquid Biopsy Tools Help Detect, Monitor Recurrent Breast Cancer
Liquid biopsy performed on serum samples from breast cancer patients can provide increasingly accurate information on cancer progression.
Read More
AI Software Spots Breast Cancer Metastases in Lymph Nodes
Paige, has launched its Paige Breast Lymph Node, an AI software that helps detect if breast cancer has metastasized to lymph nodes.
Read More
Novel Tool Helps Diagnose Inflammatory Breast Cancer
Prior to the new tool, inflammatory breast cancer lacked a formal, objective medical definition, and diagnosis was often delayed, misdiagnosed, or missed.
Read More
Novel Biomarkers Help Decode Metastatic Breast Cancer
New research has found a connection between aggressive breast cancer cells and the dual CXCR4-CCR7 cell surface protein complexes.
Read More
Improved Diagnostic Testing Needed to Guide HER2 Breast Cancer Treatment, Yale Study Finds
Using current standard HER2 assays as a diagnostic test may result in a mis-assignment for treatment of breast cancer with a promising new drug.
Read More
Illumina’s New Partnership Expands Genomic Testing in Breast Cancer
The partnership is intended to advance the use of next-generation sequencing (NGS) for decentralized oncology testing.
Read More
BioReference Laboratories Utilizes AI-Based Diagnostics Solution for Clinical Pathology
BioReference will use Gestalt Diagnostic’s Digital Pathology solution with Mindpeak’s AI cancer diagnostics algorithm for quantification of cancer cells.
Read More
Epic Sciences Launches Blood-Based Test for Metastatic Breast Cancer Patients
The novel metastatic breast cancer test includes both cell-based and cell-free analysis from a single blood draw.
Read More
Cerebrospinal Fluid Assay Identifies Mutations in Breast Cancer Patients
A new assay can identify HER2 and other tumor alterations in the cerebrospinal fluid of patients with breast cancer and leptomeningeal disease (LMD).
Read More
Roche Announces Release of AI-Based Digital Pathology Algorithms for Breast Cancer Patients
Roche will launch three new automated digital pathology algorithms, that will serve as important biomarkers for breast cancer patients.
Read More
New Breast Cancer Diagnostic Tool Seeks to Widen Age Group for Testing
The safe, painless diagnostic tool used to detect breast cancer uses a low electrical current instead of radiation.
Read More
FDA Grants Breakthrough Designation for Breast Cancer Detection Test
The US Food and Drug Administration (FDA) has granted ‘Breakthrough Device Designation’ for Datar Cancer Genetics’ ‘TriNetra’ blood test for breast cancer.
Read More